PUBBLICATO IL NUOVO NUMERO DELLA WHO PHARMACEUTICAL NEWSLETTER

Fonte: WHO. N 4, agosto 2018

E' disponibile il nuovo numero della WHO Pharmaceutical newsletter.

In questo numero:

REGULATORY MATTERS
• Amiodarone
• Benzocaine
• Cladribine
• Clarithromycin
• Daclizumab
• Darunavir
• Dasatinib
• Denosumab
• Dipeptidyl peptidase-4 (DPP-4) Inhibitor
• Eftrenonacog alfa
• Everolimus
• Fluoroquinolone antibiotics
• Granulocyte-colony stimulating factor (G-CSF) drugs
• Hydroxyethyl starch solution
• Ibrutinib
• Immunosuppressive medicines (azathioprine, ciclosporin, tacrolimus)
• Infliximab
• Metronidazole
• Pembrolizumab
• Tosufloxacin
• Valsartan

SAFETY OF MEDICINE
• Canagliflozin
• Clozapine
• Dolutegravir
• Erythropoietins
• Gadolinium based contrast agents (GBCAs)
• Hydrochlorothiazide
• Hyoscine butylbromide injection
• Imatinib
• Lysozyme-containing products
• Obeticholic acid
• Sodium-glucose cotransporter-2 (SGLT2) inhibitors
• Ulipristal acetate
• Zoledronic acid

SIGNAL
• Agomelatine – Inappropriate schedule of drug administration
• Inconsistent labelling for drug interactions

FEATURE
• Latest news from the Smart Safety Surveillance (3S) project